eCite Digital Repository

Multinational evidence-based recommendations for the use of methotrexate in rheumatic disorders with a focus on rheumatoid arthritis: integrating systematic literature research and expert opinion of a broad international panel of rheumatologists in the 3E Initiative

Citation

Visser, K and Katchamart, W and Loza, E and Martinez-Lopez, JA and Salliot, C and Trudeau, J and Bombardier, C and Carmona, L and van der Heijde, D and Bijlsma, JWJ and Boumpas, DT and Canhao, H and Edwards, CJ and Hamuryudan, V and Kvien, TK and Leeb, BF and Martin-Mola, EM and Mielants, H and Muller-Ladner, U and Murphy, G and Ostergaard, M and Pereira, IA and Ramos-Remus, C and Valentini, G and Zochling, JM and Dougados, M, Multinational evidence-based recommendations for the use of methotrexate in rheumatic disorders with a focus on rheumatoid arthritis: integrating systematic literature research and expert opinion of a broad international panel of rheumatologists in the 3E Initiative, Annals of the Rheumatic Diseases, 68, (7) pp. 1086-1093. ISSN 0003-4967 (2009) [Refereed Article]

DOI: doi:10.1136/ard.2008.094474

Abstract

Objectives: To develop evidence-based recommendations for the use of methotrexate in daily clinical practice in rheumatic disorders. Methods: 751 rheumatologists from 17 countries participated in the 3E (Evidence, Expertise, Exchange) Initiative of 2007-8 consisting of three separate rounds of discussions and Delphi votes. Ten clinical questions concerning the use of methotrexate in rheumatic disorders were formulated. A systematic literature search in Medline, Embase, Cochrane Library and 2005-7 American College of Rheumatology/European League Against Rheumatism meeting abstracts was conducted. Selected articles were systematically reviewed and the evidence was appraised according to the Oxford levels of evidence. Each country elaborated a set of national recommendations. Finally, multinational recommendations were formulated and agreement among the participants and the potential impact on their clinical practice was assessed. Results: A total of 16 979 references was identified, of which 304 articles were included in the systematic reviews. Ten multinational key recommendations on the use of methotrexate were formulated. Nine recommendations were specific for rheumatoid arthritis (RA), including the work-up before initiating methotrexate, optimal dosage and route, use of folic acid, monitoring, management of hepatotoxicity, long-term safety, mono versus combination therapy and management in the perioperative period and before/during pregnancy. One recommendation concerned methotrexate as a steroidsparing agent in other rheumatic diseases. Conclusions: Ten recommendations for the use of methotrexate in daily clinical practice focussed on RA were developed, which are evidence based and supported by a large panel of rheumatologists, enhancing their validity and practical use.

Item Details

Item Type:Refereed Article
Research Division:Medical and Health Sciences
Research Group:Clinical Sciences
Research Field:Rheumatology and Arthritis
Objective Division:Health
Objective Group:Clinical Health (Organs, Diseases and Abnormal Conditions)
Objective Field:Skeletal System and Disorders (incl. Arthritis)
Author:Zochling, JM (Dr Jane Zochling)
ID Code:54469
Year Published:2009
Web of Science® Times Cited:256
Deposited By:Menzies Institute for Medical Research
Deposited On:2009-02-23
Last Modified:2014-12-17
Downloads:0

Repository Staff Only: item control page